Table 2.
Laboratory characteristics before and after treatment with platelet-rich plasma (PRP) in for POSEIDON groups
| Variables | POSEIDON 1 Median ± IQR |
POSEIDON 2 Median ± IQR |
POSEIDON 3 Median ± IQR |
POSEIDON 4 Median ± IQR |
P-value | |
|---|---|---|---|---|---|---|
| Age (years) | 32.00 ± 3.00 | 37.00 ± 8.00 | 33.00 ± 2.00 | 40.00 ± 5.00 | < 0.001 | |
| Poor responder (%) | 2/7 (28.6%) | 8/17 (47.1%) | 12/16 (75%) | 47/56 (83.9%) | 0.002 | |
| Number of previous punctures | 3 ± 2 | 3 ± 1 | 2.5 ± 1 | 2.00 ± 2.00 | 0.755 | |
| LH (IU/L) | Before PRP | 1.87 ± 1.50 | 2.35 ± 2.82 | 2.51 ± 1.30 | 3.02 ± 1.75 | 0.160 |
| After PRP | 2.08 ± 1.43 | 2.98 ± 1.68 | 2.82 ± 2.20 | 3.05 ± 2.29 | 0.198 | |
| FSH (IU/mL) | Before PRP | 4.27 ± 1.73 | 5.79 ± 2.65 | 6.08 ± 5.19 | 6.66 ± 5.11 | 0.054 |
| After PRP | 5.15 ± 1.63 | 5.60 ± 3.20 | 6.85 ± 4.23 | 7.21 ± 4.04 | 0.028 | |
| Estradiol (pg/mL) | Before PRP | 31.00 ± 55.9 | 46.00 ± 16.65 | 57.15 ± 40.10 | 51.60 ± 34.10 | 0.576 |
| After PRP | 55.80 ± 20.30 | 51.70 ± 23.30 | 62.00 ± 45.68 | 45.00 ± 33.38 | 0.342 | |
| AMH (ng/mL) | Before PRP | 1.75 ± 2.07 | 1.68 ± 0.98 | 0.6 ± 0.45 | 0.46 ± 0.51 | < 0.001 |
| After PRP | 1.85 ± 2.56 | 1.53 ± 1.03 * | 0.64 ± 0.68 | 0.50 ± 0.56 | < 0.001 | |
IQR Interquartile range, LH Luteinizing hormone, FSH Follicle-stimulating hormone, AMH Anti-Mullerian hormone
*: p-value < 0.05, **: p-value < 0.01, and ***: p-value < 0.001 all compare to the before level